BIZILY SCOTT (Chief Legal Officer) sold 15.9% of their position (1.64K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $21.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2026ACC: 0001193125-26-426810
Officer· Chief Legal Officer
Since Mar 2022
-1.64K
Net shares
Net seller
$21.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.64K acquired · 3.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.64K
Price / share
$4.14
Trade value
$6.77K
% of position
19.0%
10/16/2026
8.62K→10.25K
Common Stock
Direct
Shares
−1.64K
Price / share
$12.84
Trade value
$20.99K
% of position
15.9%
10/16/2026
10.25K→8.62K
Total
Net shares
+0.00
Net value
-$14.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2026 | M · Option Exercise | +1.64K | $4.14 | $6.77K | 19.0% | 8.62K | 10.25K |
| Common Stock Direct | 10/16/2026 | S · Sale | −1.64K | $12.84 | $20.99K | 15.9% | 10.25K | 8.62K |
| Total | +0.00 | -$14.22K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.64K shares
Shares
−1.64K
Strike price
4.14
Held after
56.43K
Exercisable
—
10/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.64K shares | 10/16/2026 | M · Option Exercise | −1.64K | 4.14 | — | 56.43K |